Glial cell line-derived neurotrophic factor protects against 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice

Neuroscience Letters

Volumn 252, Issue 2, 1998, Pages 87-90

  Cheng, Fu Chou ^a   Ni, Dah Ren ^a   Wu, Ming Chi ^b   Kuo, Jon Son ^a   Chia, Lie Gan ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Glial cell line derived neurotrophic factor; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; META TYROSINE; NEURITE PROMOTING FACTOR; RECOMBINANT NEURITE PROMOTING FACTOR; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN PROTECTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; MOUSE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGENTS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; LOCOMOTION; MICE; MICE, INBRED C57BL; MPTP POISONING; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PARKINSON DISEASE, SECONDARY; SEROTONIN;

EID: 0032563356     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00554-0     Document Type: Article

References (18)

1. Adolfsson R., Gottfries C.G., Roos B.E., Winblad B.J. Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J. Neural Transm. 45:1979;81-105.
2. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
3. Cheng F.C., Yang L.L., Lin S.K., Juang D.J., Chang W.H., Kuo J.S. Determination of human plasma biogenic amines and their metabolites using liquid chromatography with a dual-channel electrochemical detector. Chin. Med. J. (Taipei). 55:1995;15-24.
4. Chia L.G., Liu S.P., Lee E.H. Differential effects of deprenyl and MPTP on catecholamines and activity in BALB/c mice. Neuroreport. 3:1992;777-780.
5. Chia L.G., Ni D.R., Cheng L.J., Kuo J.S., Chang F.L., Dryhurst G. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 5,7-dihydroxytryptamine on the locomotor activity and striatal amines in C57BL/6 mice. Neurosci. Lett. 218:1996;67-71.
6. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. New Engl. J. Med. 318:1988;876-880.
7. German D.C., Manaye K.F., Sonsalla P.K., Brooks B.A. Midbrain dopaminergic cell loss in PD and MPTP-induced Parkinsonism: sparing of calbindin-D28k-containing cells. Ann, N.Y. Acad. Sci. 648:1992;42-62.
8. Henderson C.E. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 266:1994;1062.
9. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45:1986;19-34.
10. Hornykiewicz O. Ageing and neurotoxins as causative factors in idopathic PD- a critical analysis of the neurochemical evidence. Prog. Neuro. Psychopharmacol. Biol. Psychiatry. 13:1989;319-328.
11. Hu S.C., Chang F.W., Sung Y.J., Hsu W.M., Lee S.H. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB/c mice. Am. Soc. Pharm. Exp. Therapeutics. 259:1991;1379-1387.
12. Jellinger K. Overview of morphological changes in Parkinson's disease. Adv. Neurol. 45:1987;1-18.
13. Lee E.H., Lin Y.P., Yin T.H. Effects of lateral and medial septal lesions on various activity and reactivity measures in rats. Physiol. Behav. 42:1987;97-102.
14. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
15. Lin L.F., Zhang T.J., Collins F., Armes L.G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63:1994;758-768.
16. Oppenheim R.W., Houenou L.J., Johnson J.E., Lin L.F., Li L., Lo A.C., Newsome A.L. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature. 373:1995;344-346.
17. Tomac A., Lindquist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
18. Yan Q., Matheson C., Lopez O.T. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature. 373:1995;341-344.